Citigroup’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Sell |
40,000
-255,000
| -86% | -$24.4M | ﹤0.01% | 2255 |
|
|
2025
Q4 | $28.3M | Hold |
295,000
| – | – | 0.01% | 915 |
|
|
2025
Q3 | $28.1M | Buy |
295,000
+10,000
| +4% | +$919K | 0.01% | 889 |
|
|
2025
Q2 | $24.8M | Buy |
285,000
+50,000
| +21% | +$4.24M | 0.01% | 864 |
|
|
2025
Q1 | $21.1M | Buy |
235,000
+185,000
| +370% | +$16.6M | 0.01% | 948 |
|
|
2024
Q4 | $3.99M | Hold |
50,000
| – | – | ﹤0.01% | 2186 |
|
|
2024
Q3 | $4.5M | Hold |
50,000
| – | – | ﹤0.01% | 1942 |
|
|
2024
Q2 | $3.94M | Buy |
+50,000
| New | +$4.1M | ﹤0.01% | 1808 |
|
|
2023
Q1 | – | Sell |
-4,200
| Closed | -$326K | – | 5717 |
|
|
2022
Q4 | $326K | Sell |
4,200
-20,000
| -83% | -$1.62M | ﹤0.01% | 3453 |
|
|
2022
Q3 | $1.95M | Hold |
24,200
| – | – | ﹤0.01% | 2159 |
|
|
2022
Q2 | $2.17M | Sell |
24,200
-18,300
| -43% | -$1.85M | ﹤0.01% | 2047 |
|
|
2022
Q1 | $4.71M | Sell |
42,500
-141,500
| -77% | -$14.9M | ﹤0.01% | 1706 |
|
|
2021
Q4 | $19M | Sell |
184,000
-32,200
| -15% | -$3.73M | 0.01% | 1035 |
|
|
2021
Q3 | $27.1M | Buy |
216,200
+18,000
| +9% | +$2.33M | 0.02% | 821 |
|
|
2021
Q2 | $24.6M | Buy |
198,200
+126,400
| +176% | +$15.9M | 0.01% | 882 |
|
|
2021
Q1 | $8.48M | Sell |
71,800
-270,600
| -79% | -$31.7M | 0.01% | 1465 |
|
|
2020
Q4 | $40.1M | Buy |
342,400
+16,000
| +5% | +$1.76M | 0.02% | 647 |
|
|
2020
Q3 | $33.9M | Buy |
326,400
+19,600
| +6% | +$1.97M | 0.02% | 637 |
|
|
2020
Q2 | $28.1M | Sell |
306,800
-188,900
| -38% | -$18.1M | 0.02% | 646 |
|
|
2020
Q1 | $44.7M | Sell |
495,700
-78,000
| -14% | -$8.3M | 0.04% | 396 |
|
|
2019
Q4 | $65.1M | Buy |
573,700
+80,400
| +16% | +$8.82M | 0.05% | 392 |
|
|
2019
Q3 | $53.6M | Sell |
493,300
-11,800
| -2% | -$1.23M | 0.04% | 422 |
|
|
2019
Q2 | $49.2M | Buy |
505,100
+118,900
| +31% | +$10.9M | 0.04% | 445 |
|
|
2019
Q1 | $35.2M | Sell |
386,200
-173,000
| -31% | -$15.5M | 0.03% | 540 |
|
|
2018
Q4 | $50.9M | Buy |
559,200
+27,800
| +5% | +$2.6M | 0.05% | 395 |
|
|
2018
Q3 | $52.3M | Buy |
531,400
+289,100
| +119% | +$26.7M | 0.05% | 368 |
|
|
2018
Q2 | $20.7M | Sell |
242,300
-174,500
| -42% | -$14.6M | 0.02% | 783 |
|
|
2018
Q1 | $33.4M | Buy |
416,800
+14,600
| +4% | +$1.2M | 0.03% | 538 |
|
|
2017
Q4 | $32.5M | Sell |
402,200
-103,200
| -20% | -$8.27M | 0.03% | 593 |
|
|
2017
Q3 | $39.3M | Buy |
505,400
+361,700
| +252% | +$30M | 0.03% | 492 |
|
|
2017
Q2 | $12.8M | Sell |
143,700
-19,300
| -12% | -$1.63M | 0.01% | 985 |
|
|
2017
Q1 | $13.1M | Sell |
163,000
-193,945
| -54% | -$15.1M | 0.01% | 961 |
|
|
2016
Q4 | $25.4M | Buy |
356,945
+261,430
| +274% | +$20.5M | 0.02% | 635 |
|
|
2016
Q3 | $8.25M | Sell |
95,515
-137,500
| -59% | -$12M | 0.01% | 1230 |
|
|
2016
Q2 | $20.2M | Buy |
233,015
+100,100
| +75% | +$8.09M | 0.02% | 642 |
|
|
2016
Q1 | $9.97M | Sell |
132,915
-196,675
| -60% | -$14.8M | 0.01% | 1012 |
|
|
2015
Q4 | $25.4M | Buy |
329,590
+69,915
| +27% | +$5.26M | 0.03% | 633 |
|
|
2015
Q3 | $17.4M | Buy |
259,675
+89,660
| +53% | +$6.6M | 0.02% | 788 |
|
|
2015
Q2 | $12.6M | Sell |
170,015
-75,580
| -31% | -$5.77M | 0.01% | 1053 |
|
|
2015
Q1 | $19.2M | Sell |
245,595
-130,305
| -35% | -$9.88M | 0.02% | 800 |
|
|
2014
Q4 | $27.1M | Buy |
375,900
+151,100
| +67% | +$10.5M | 0.02% | 650 |
|
|
2014
Q3 | $13.9M | Sell |
224,800
-26,200
| -10% | -$1.67M | 0.01% | 1039 |
|
|
2014
Q2 | $16M | Sell |
251,000
-12,500
| -5% | -$759K | 0.02% | 933 |
|
|
2014
Q1 | $16.2M | Sell |
263,500
-259,100
| -50% | -$15.1M | 0.02% | 835 |
|
|
2013
Q4 | $30M | Buy |
522,600
+61,000
| +13% | +$3.46M | 0.03% | 571 |
|
|
2013
Q3 | $24.6M | Buy |
461,600
+82,400
| +22% | +$4.43M | 0.02% | 635 |
|
|
2013
Q2 | $19.5M | Buy |
+379,200
| New | +$18.7M | 0.02% | 701 |
|
Other funds holding MDT
VCM
VPM
Citigroup's MDT Position: Q1 2026 in Review
Citigroup increased its Medtronic (MDT) stake by 4.2% in Q1 2026, buying an estimated $5.22M and bringing the position to 1,337,911 shares worth $116M. The position accounts for 0.05% of the portfolio, ranked #359.
Citigroup first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $309M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Citigroup held 1,337,911 shares of Medtronic worth $116M as of Q1 2026.
- Citigroup bought 54,444 Medtronic shares in Q1 2026, an estimated $5.22M.
- Medtronic made up 0.05% of Citigroup's portfolio in Q1 2026, its #359 holding.
- Citigroup first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Medtronic position peaked at $309M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.